BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
BRCA1
,
nitric oxide metabolic process
,
Ischemia
,
Prostate
,
Personalized medicine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SMARCB1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Skeletal muscle psoas
B lymphocyte (IgM memory) of spleen
Testis seminiferous tubule
Testes
Cerebellum peduncles
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
SMARCB1-deficient renal medullary carcinoma with revealed by a supra-clavicular metastatic lymph nod…
SMARCB1 (INI1)-deficient sinonasal carcinoma manifesting as oral lesions: A report of two cases.
SMARCB1 Loss in Poorly Differentiated Chordomas Drives Tumor Progression.
SMARCB1-deficient malignant neoplasm of the pancreas with heterogeneous morphologies that cannot be …
SMARCB1/INI1-deficient epithelioid and myxoid neoplasms in paratesticular region: Expanding the clin…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Induction Chemotherapy and Tazemetostat for Locally Advanced SMARCB1-deficient Sinonasal Carcinoma
A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-P…
FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors
Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficien…
Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lym…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ